Dosing a statin (rosuvastatin) every other day (EOD) may provide significant lipoprotein changes while avoiding common adverse effects in this statin-intolerant population. Objective: To determine ...
There are small but important differences in risk for some clinical outcomes associated with rosuvastatin and atorvastatin, according to a study published online Oct. 29 in Annals of Internal ...
The authors assessed the efficacy and safety of rosuvastatin monotherapy, extended-release (ER) niacin monotherapy, or rosuvastatin and ER niacin combined therapy in patients with atherogenic ...
Compared with atorvastatin, whether for primary or secondary prevention, rosuvastatin initiation had lower risk for all-cause mortality and MACE in both the Chinese and UK databases. The number needed ...
A nationally representative study of Medicare beneficiaries with modest incomes found that up to half of them may not have sufficient funds to cover out-of-pocket costs associated with a single ...
The researchers described the extreme “pre-morbid” vulnerability of older hostages along with the additional data on their clinical situation and extreme stresses to which they are being subjected.